PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q4 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,734 | -32.4% | 168,921 | -8.0% | 0.00% | – |
| Q2 2023 | $525,044 | -74.3% | 183,582 | -73.8% | 0.00% | – |
| Q1 2023 | $2,041,220 | +6.4% | 701,450 | +7.2% | 0.00% | – |
| Q4 2022 | $1,917,735 | +24.2% | 654,517 | +1.8% | 0.00% | – |
| Q3 2022 | $1,544,000 | +7.3% | 643,174 | +0.1% | 0.00% | – |
| Q2 2022 | $1,439,000 | +1.8% | 642,374 | +4.5% | 0.00% | – |
| Q1 2022 | $1,414,000 | -7.8% | 614,625 | +0.2% | 0.00% | – |
| Q4 2021 | $1,534,000 | – | 613,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 1,033,130 | $3,027,071 | 8.27% |
| K2 PRINCIPAL FUND, L.P. | 732,105 | $2,145,068 | 0.33% |
| EQUITEC PROPRIETARY MARKETS, LLC | 330,694 | $968,933 | 0.31% |
| SABBY MANAGEMENT, LLC | 97,978 | $287,076 | 0.25% |
| FNY Investment Advisers, LLC | 31,100 | $90 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 40,800 | $119,544 | 0.02% |
| Aspire Private Capital, LLC | 800 | $2,344 | 0.00% |
| Schonfeld Strategic Advisors LLC | 25,200 | $73,836 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,758 | $6,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 98 | $286 | 0.00% |